Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies

Therapeutics and Clinical Risk Management · Published 2026-07-01 · DOI 10.2147/tcrm.s547154

Free full text

Authors (8)

Qiu-Chan Deng, Wen-Bin Kuang, Yu-Jing Yang, Cai-Ping Gong, Yi-Peng Zhang, Qiong Luo, Liu-Ping Luo, Guang-Ming Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Deng, Q., Kuang, W., Yang, Y., et al. (2026). Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.s547154

Related articles